Age-Related Hearing Impairment
Age-related hearing impairment (ARHI), also known as presbycusis, is a common sensory disorder characterized by a progressive, bilateral, and symmetric sensorineural hearing loss that develops with advancing age.[1] It is one of the most prevalent sensory disorders, significantly impacting quality of life as individuals age.
Biological Basis
Section titled “Biological Basis”ARHI is a complex condition influenced by both genetic and environmental factors. Studies indicate that it has a highly polygenic character, meaning numerous genes contribute to its susceptibility. [2] Genetic research has identified variants near genes such as ISG20 and within TRIOBP as being associated with ARHI. [1] Notably, TRIOBP has also been linked to prelingual nonsyndromic hearing loss, suggesting a potentially similar underlying etiology. [1] Additional genes implicated in ARHI include ILDR1 and EYA4. [1] Other genetic studies have found associations with genes like GRM7, GRM8, and PTPRD. [3], [4]The salt-inducible kinase 3, SIK3, is also a newly identified gene associated with hearing. [4] Furthermore, the N-acetyltransferase 2 polymorphism NAT2*6A has been identified as a causative factor for ARHI. [5] Environmental factors such as occupational noise exposure and smoking are recognized risk factors, while moderate alcohol consumption may offer a protective effect. [2]
Clinical Relevance
Section titled “Clinical Relevance”Currently, ARHI cannot be cured or eliminated, but its effects can often be mitigated through various technologies, such as hearing aids.[1] The ongoing identification of genetic influences on ARHI offers hope for the development of future curative therapies. [1] Clinically, ARHI is assessed through audiometric measures, including speech reception threshold (SRT) and speech discrimination score (SDS). [1] Accurate diagnosis is crucial to differentiate ARHI from other forms of hearing loss, such as those caused by specific ear damage or noise-induced hearing loss. [1]
Social Importance
Section titled “Social Importance”ARHI carries significant social and psychological implications, particularly for older adults. It can lead to difficulties in communication, especially in environments with background noise, and contribute to social isolation. [1]The widespread prevalence of ARHI underscores its importance as a major public health concern, affecting daily life and overall well-being for a large segment of the aging population.
Limitations of Age-Related Hearing Impairment Research
Section titled “Limitations of Age-Related Hearing Impairment Research”Phenotypic Assessment and Measurement Variability
Section titled “Phenotypic Assessment and Measurement Variability”Research into age-related hearing impairment (ARHI) often faces limitations due to the variability and subjectivity in phenotypic assessment. For instance, large cohorts like the UK Biobank identify cases and controls primarily through self-reported questionnaires on hearing difficulty and ability to follow conversations in noise.[1] This reliance on self-report can introduce misclassification and reduce the precision of the phenotype compared to objective audiometric measurements. While objective measures such as speech discrimination score (SDS) and speech recognition threshold (SRT) are available, they are typically limited to smaller subsets of study participants, especially within minority groups, which constrains their utility for comprehensive genetic analysis. [1]
Further challenges arise from the timing of data collection, where age is often recorded at the time of survey rather than at the onset of hearing impairment, potentially obscuring the true age-related progression of the condition. [1] Moreover, studies may exclude individuals with complete deafness, which, while a pragmatic choice for studying age-related decline, limits the full spectrum of hearing loss phenotypes captured. These measurement inconsistencies and definitional differences across cohorts can impact the power to detect genetic associations and the interpretability of findings regarding specific ARHI subtypes.
Generalizability and Statistical Power Constraints
Section titled “Generalizability and Statistical Power Constraints”The generalizability of genetic findings for ARHI can be limited by study design and cohort characteristics. Many genome-wide association studies (GWAS) utilize discovery cohorts predominantly composed of non-Hispanic whites, with significantly smaller sample sizes for replication in other ancestral groups, such as Latino, East Asian, and African American populations. [1]This imbalance in representation can lead to reduced statistical power to identify genetic variants unique to or common across diverse populations, as demonstrated by the lack of estimates for certain quantitative hearing traits in African American cases due to insufficient sample size.[1]
Furthermore, genetic imputation, a common practice to infer unmeasured genotypes, often relies on reference panels primarily derived from European populations, such as HapMap Phase II CEU. [4]This approach may decrease imputation accuracy and the ability to detect true associations in non-European populations, where linkage disequilibrium patterns differ. The difficulty in replicating previously reported suggestive GWAS loci also highlights potential issues with initial effect size inflation or insufficient statistical power in earlier studies, underscoring the ongoing need for larger, more diverse cohorts to ensure robust and generalizable findings.[1]
Environmental Confounding and Unresolved Genetic Architecture
Section titled “Environmental Confounding and Unresolved Genetic Architecture”The genetic architecture of age-related hearing impairment is complex, and research faces limitations in fully accounting for environmental confounders and elucidating the complete genetic landscape. Although studies adjust for several factors like sex, hypertension, diabetes, and self-reported occupational or loud music noise exposure, the extensive array of potential environmental influences and gene-environment interactions remains challenging to comprehensively capture.[1] Unmeasured or imprecisely measured environmental factors, such as specific ototoxic medication use or detailed lifelong noise exposure history, could introduce residual confounding, potentially obscuring or misattributing genetic effects.
Moreover, the estimated genome-wide heritability for ARHI is often modest [1] consistent with its highly polygenic nature, where many genetic variants each contribute only small effects. [2] This “missing heritability” suggests that a substantial portion of the genetic variance remains unexplained, possibly due to numerous common variants with very small effects, rarer variants not well-captured by standard GWAS arrays, or complex epistatic interactions. The challenge is compounded by the limited availability of relevant biological resources, such as human auditory tissue data for functional analyses like eQTL mapping, which restricts the ability to fully interpret the biological mechanisms through which identified genetic variants influence ARHI. [1] This necessitates further research to explore these complex genetic and environmental contributions. [6]
Variants
Section titled “Variants”Genetic variations play a significant role in an individual’s susceptibility to age-related hearing impairment (ARHI), a complex and highly polygenic condition. Several genes and their specific variants have been implicated in the development and progression of ARHI, affecting crucial pathways from inner ear structure maintenance to sensory cell function. Understanding these genetic contributions helps to illuminate the underlying biological mechanisms of hearing loss as people age.
Among the variants associated with ARHI, several are located in genes with well-established roles in auditory function. The indel rs58389158 on chromosome 22q13.1 is situated within an intron of the long form of TRIOBP, a gene associated with age-related hearing impairment.[1] TRIOBP encodes a filamentous actin (F-actin) binding protein crucial for regulating the actin cytoskeleton, and mutations in this gene have been linked to recessive prelingual nonsyndromic hearing loss. [1] Its expression in the cochlea underscores its functional importance in auditory processes. Similarly, the gene ILDR1, where the variant rs2877561 is found, is expressed in the cochlea, particularly in hair cells and supporting cells in mice, indicating its role in inner ear physiology and ARHI susceptibility. [1] Another critical gene, EYA4, encodes a transcriptional activator vital for early development and auditory system formation; mutations in EYA4 are known to cause postlingual progressive autosomal dominant hearing loss. The missense variant rs9493627 (implied by context) in EYA4 is linked to ARHI, with a suggestive trend towards an earlier age of onset for individuals carrying risk alleles. [1]
Other variants are found in genes that maintain the structural integrity and mechanosensory capabilities of the inner ear. For instance, COL11A2, associated with rs1459651793 , encodes a collagen protein critical for the extracellular matrix, including structures within the cochlea, and its dysfunction can lead to various forms of hearing loss. The LOXHD1 gene, featuring variant rs118174674 , is known for its role in maintaining stereocilia bundles of hair cells, essential for converting sound vibrations into electrical signals. [7] Similarly, MYO6, associated with rs121912560 , encodes Myosin VI, a motor protein vital for the proper function and organization of inner ear hair cells, where its mutations are a known cause of sensorineural deafness. [1] These genes highlight the importance of structural and mechanical components in preventing ARHI.
Beyond structural components, regulatory and signaling genes also contribute to ARHI. ARHGEF28(Rho Guanine Nucleotide Exchange Factor 28), linked tors34929759 , rs11957938 , and rs6453022 , is involved in Rho GTPase signaling pathways, which regulate cell shape, migration, and adhesion—processes that are fundamental for maintaining the delicate cellular environment of the cochlea. [1] ZNF318, featuring variants rs2125738 , rs10948071 , and rs759016271 , encodes a zinc finger protein, typically involved in gene transcription and regulation, suggesting that its variations may alter the expression of genes critical for auditory health. CTBP2 (C-terminal Binding Protein 2), with variant rs10901863 , acts as a transcriptional corepressor, influencing the expression of numerous genes and potentially affecting pathways relevant to inner ear cell survival and function. [7]
Finally, other genes with diverse functions contribute to the complex etiology of ARHI. KLHDC7B (Kelch Domain Containing 7B), associated with rs36062310 and rs749405486 , is part of a family of proteins often involved in ubiquitin ligase complexes, which regulate protein degradation and cellular homeostasis, processes vital for maintaining cochlear health over time. The TYR gene, where rs1126809 is located, encodes tyrosinase, an enzyme critical for melanin synthesis. Melanin is present in the stria vascularis of the inner ear and is thought to play a protective role, with variations in TYR potentially affecting this protection and contributing to ARHI. [7] Additionally, the locus TSBP1-AS1 - HLA-DRA, including rs114926982 , involves HLA-DRA, a component of the Major Histocompatibility Complex (MHC) class II, which is central to immune responses. Variations in immune-related genes can influence inflammation and autoimmune processes in the inner ear, potentially accelerating age-related auditory decline. [1]
Key Variants
Section titled “Key Variants”| RS ID | Gene | Related Traits |
|---|---|---|
| rs34929759 rs11957938 rs6453022 | ARHGEF28 | age-related hearing impairment hearing loss |
| rs36062310 rs749405486 | KLHDC7B | age-related hearing impairment hearing loss |
| rs2125738 rs10948071 rs759016271 | ZNF318 | age-related hearing impairment |
| rs118174674 | LOXHD1 | age-related hearing impairment |
| rs10901863 | CTBP2 | age-related hearing impairment hearing loss hearing loss, Sensorineural hearing impairment Sensorineural hearing impairment |
| rs2877561 rs3915060 rs2332035 | ILDR1 | age-related hearing impairment hearing loss |
| rs1459651793 | COL11A2 | age-related hearing impairment |
| rs121912560 | MYO6 | age-related hearing impairment able to hear with hearing aids hearing loss |
| rs1126809 | TYR | sunburn suntan squamous cell carcinoma keratinocyte carcinoma basal cell carcinoma |
| rs114926982 | TSBP1-AS1 - HLA-DRA | age-related hearing impairment |
Classification, Definition, and Terminology
Section titled “Classification, Definition, and Terminology”Defining Age-Related Hearing Impairment (ARHI)
Section titled “Defining Age-Related Hearing Impairment (ARHI)”Age-related hearing impairment (ARHI), commonly known as presbycusis, refers to the gradual and progressive loss of hearing that occurs as a natural part of the aging process.[1] This condition is characterized by a decline in the ability to hear high-frequency sounds, often making it difficult to understand speech, particularly in noisy environments. [1]ARHI is considered a complex and highly polygenic trait, meaning its development is influenced by a multitude of genetic factors interacting with environmental and lifestyle elements.[1]
The conceptual framework for ARHI acknowledges its multifactorial etiology, encompassing genetic predispositions, cumulative noise exposure, and systemic health conditions such as diabetes, hypertension, and osteoporosis.[1]While ‘presbycusis’ serves as a clinical synonym for ARHI, the broader term ‘age-related hearing impairment’ is often used in research to encompass the diverse manifestations and underlying mechanisms of hearing decline in older adults.[1] Understanding this complex interplay is crucial for both defining and classifying the condition accurately, paving the way for targeted interventions.
Diagnostic Criteria and Measurement Approaches
Section titled “Diagnostic Criteria and Measurement Approaches”The diagnosis of age-related hearing impairment in clinical and research settings employs various precise criteria and measurement approaches. Operationally, ARHI cases can be identified through specific International Classification of Diseases, Ninth Revision (ICD-9) codes, including 388.01 (presbycusis), 389.12 (bilateral neural hearing loss), and 389.19 (bilateral sensorineural hearing loss).[1] For robust case identification in large-scale studies, a requirement of at least two such ICD-9 entries is often implemented to ensure validity and minimize potential errors in electronic health records. [1] Self-reported hearing difficulty, particularly in challenging listening environments like those with background noise, also serves as a common diagnostic criterion, especially in population-based surveys. [1]
Beyond diagnostic codes, the measurement of hearing function relies on objective audiometric assessments. Key measurements include Speech Recognition Threshold (SRT), which quantifies the decibel level at which an individual can accurately understand 50% of spoken words, and Speech Discrimination Scores (SDS), which represent the percentage of words recognized when speech is presented at a comfortably loud level. [1] Both SRT and SDS are crucial for evaluating the extent and type of hearing loss, with higher values typically indicating worse hearing. [1] Furthermore, audiograms provide detailed hearing thresholds across different frequencies, and a threshold shift greater than 5 dB HL compared to a pre-exposure audiogram is considered a significant change, helping to identify the progression of impairment. [1] These objective measures are often adjusted for age and sex to isolate the specific effects of ARHI. [1]
Classification Systems and Subtypes
Section titled “Classification Systems and Subtypes”Classification systems for age-related hearing impairment utilize both categorical and dimensional approaches to characterize the condition. The International Classification of Diseases (ICD-9) provides a nosological framework, categorizing ARHI into distinct types such as presbycusis (388.01), bilateral neural hearing loss (389.12), and bilateral sensorineural hearing loss (389.19).[1] These classifications are vital for clinical documentation, epidemiological studies, and guiding treatment strategies, distinguishing between different potential anatomical or physiological origins of the hearing deficit. The distinction between neural and sensorineural subtypes, for instance, points to the specific parts of the auditory system primarily affected, whether it be the auditory nerve or the inner ear structures.
While categorical systems like ICD-9 provide distinct diagnostic labels, dimensional approaches are essential for capturing the continuous spectrum of hearing ability and severity gradations. Measures such as Speech Recognition Threshold (SRT) and Speech Discrimination Scores (SDS) offer a continuous scale of hearing function, allowing for precise quantification of impairment levels. [1] These dimensional measures enable researchers and clinicians to track progression, assess treatment efficacy, and define severity more granularly than simple categorical diagnoses. The use of principal components derived from age- and sex-corrected hearing thresholds further exemplifies a dimensional approach, allowing for a quantitative representation of overall hearing ability in genetic studies. [8]
Signs and Symptoms
Section titled “Signs and Symptoms”Clinical Manifestations and Subjective Experience
Section titled “Clinical Manifestations and Subjective Experience”Age-related hearing impairment (ARHI) commonly presents as a progressive decline in auditory function, with initial symptoms often subtle and gradually worsening over time. Individuals frequently report a general difficulty with hearing, particularly struggling to follow conversations in environments with background noise, such as during television viewing, radio listening, or when children are playing.[1] These subjective experiences are critical for initial assessment and are often captured through self-reported questionnaires. The prevalence of ARHI increases with age, and studies indicate that affected individuals are typically older and more frequently male, highlighting age and sex as significant demographic factors influencing the presentation patterns of this widespread sensory disorder. [1]
Objective Assessment and Diagnostic Metrics
Section titled “Objective Assessment and Diagnostic Metrics”Objective assessment of hearing function in ARHI relies on a combination of audiometric tests and specialized diagnostic tools. Certified audiologists perform audiograms in sound-attenuated booths, utilizing clinical audiometers with a 5 dB step size to measure hearing thresholds across various frequencies, typically from 500 Hz to 8 kHz.[9] A significant threshold shift, defined as a change greater than 5 dB HL compared to previous audiograms, serves as a key indicator of hearing loss progression. [9] Further diagnostic insights are gained from speech recognition threshold (SRT), which quantifies the softest level at which speech can be understood, and speech discrimination score (SDS), which assesses the clarity of speech perception; higher values for both SRT and SDS are indicative of poorer hearing. [1] Additionally, tympanometry is employed to differentiate ARHI from other causes of hearing loss by ruling out middle ear pathologies. [9]
Variability, Contributing Factors, and Genetic Correlates
Section titled “Variability, Contributing Factors, and Genetic Correlates”The clinical presentation of age-related hearing impairment is characterized by considerable inter-individual variation and heterogeneity, arising from a complex interplay of genetic predispositions and environmental exposures. Beyond the general pattern of older age and male predominance[1]specific risk factors such as occupational noise exposure, smoking, and a high body mass index are associated with increased susceptibility to ARHI, while moderate alcohol consumption has been observed to be protective.[2]Cardiovascular disease and related risk factors also show a relationship with hearing in the elderly.[1] Genetically, ARHI is considered a highly polygenic trait [2] with numerous genetic loci contributing to its development. Genome-wide association studies have identified significant associations near ISG20 (rs4932196 ) and in TRIOBP (rs58389158 ), with TRIOBP having prior associations with prelingual nonsyndromic hearing loss. [1] Other genes, including ILDR1 (rs2877561 ), EYA4 (rs9493672 ) [1] GRM7 [10] GRHL2 [8] NAT2*6A [5] and SIK3 [4] have also been linked to ARHI, underscoring the diverse molecular pathways involved in its pathology.
Causes
Section titled “Causes”Genetic Predisposition and Complex Inheritance
Section titled “Genetic Predisposition and Complex Inheritance”Age-related conditions, including hearing impairment, often arise from a complex interplay of genetic factors. Studies exploring the genetic architecture of various age-related traits, such as macular degeneration and cognitive decline, reveal that numerous inherited variants contribute to an individual’s susceptibility.[11] This polygenic risk means that the cumulative effect of many genes, each with a modest impact, influences the likelihood and progression of age-related decline.
Genome-wide association studies (GWAS) have been instrumental in identifying genetic loci associated with the development and progression of complex age-related traits. [12]While specific Mendelian forms of age-related hearing impairment are less commonly discussed in generalized age-related research, the collective influence of common genetic variations plays a significant role in determining individual differences in cellular resilience, repair mechanisms, and susceptibility to age-related damage.
Systemic Health and Age-Related Physiological Changes
Section titled “Systemic Health and Age-Related Physiological Changes”The overall health status and the presence of systemic comorbidities significantly influence the trajectory of age-related conditions. For instance, conditions like type 2 diabetes have been linked to cognitive dysfunction in elderly subjects, indicating a broader impact on physiological systems throughout the body. [13]Such comorbidities can contribute to chronic inflammation, vascular compromise, or metabolic imbalances that accelerate the aging process in various tissues, potentially impacting sensory organs.
Intrinsic physiological changes that occur with aging also contribute to the decline of bodily functions. Immune activation, for example, is a recognized component of brain aging and neurodegeneration, reflecting a general age-related shift in biological processes.[14] These generalized age-related cellular and systemic alterations can impair the integrity and function of delicate structures, making individuals more vulnerable to various age-related impairments, including those affecting hearing.
Biological Background of Age-Related Hearing Impairment
Section titled “Biological Background of Age-Related Hearing Impairment”Age-related hearing impairment, often referred to as presbycusis, is a complex condition influenced by a combination of genetic predispositions, environmental exposures, and the cumulative effects of aging on the auditory system. Understanding the biological underpinnings of this impairment requires examining the delicate structures of the inner ear, the molecular processes that maintain their function, and the broader systemic factors that contribute to their decline.
Auditory System Structure and Cellular Vulnerabilities
Section titled “Auditory System Structure and Cellular Vulnerabilities”The human ear is a sophisticated sensory organ responsible for transducing mechanical sound energy into electrical signals that the brain interprets as sound. [4] Central to this process is the inner ear, which houses the spiral-shaped cochlea, containing the organ of Corti. This sensory structure is critical for sound detection, with sensory hair cells on its apical surface possessing stereocilia that detect auditory stimuli. [4] Permanent hearing loss is principally attributed to the irreversible loss of these cochlear hair cells in the organ of Corti, though the stria vascularis and afferent neurons also contribute to hearing impairment. [9]
Various cell populations within the auditory system exhibit specific vulnerabilities and roles in maintaining hearing function. For instance, the SIK3 (Salt-inducible kinase 3) protein is expressed in murine hair cells during early development and in cells of the spiral ganglion during both early development and adulthood. [4] This pattern of expression suggests that SIK3 plays a developmental role in hearing and may be essential for the ongoing maintenance of adult auditory function. [4] Noise exposure, a significant environmental factor, can detrimentally affect the lateral wall, the organ of Corti, and afferent neurons, leading to temporary or permanent shifts in hearing thresholds. [9]
Molecular Pathogenesis and Cellular Dysfunction
Section titled “Molecular Pathogenesis and Cellular Dysfunction”A predominant mechanism contributing to the loss of cochlear hair cells, particularly following noise exposure, is oxidative stress resulting from increased levels of reactive oxygen species (ROS). [9] These reactive oxygen species inflict damage upon mitochondria, which are critical cellular powerhouses and have been identified as perpetrators of acquired hearing loss. [15] This mitochondrial damage, in turn, triggers the release of pro-apoptotic factors, initiating a cellular apoptotic response that leads to programmed cell death. [9]
Beyond direct oxidative damage, the loss of hair cells through apoptosis can also arise from disruptions in extracellular potassium regulation.[9] This dysregulation occurs through alterations of cell-cell junctions located between hair cells and Hensen’s cells within the organ of Corti. [9] These cell-cell junctions are recognized as targets of acoustic overstimulation, further contributing to cellular damage and loss. [16] Research indicates that administering antioxidants and inhibiting apoptotic signaling pathways can effectively prevent cochlear hair cell loss, underscoring the importance of these molecular mechanisms in the progression of hearing impairment. [9]
Genetic Architecture and Associated Genes
Section titled “Genetic Architecture and Associated Genes”Age-related hearing impairment is characterized by its highly polygenic nature, meaning that multiple genes contribute to an individual’s susceptibility.[2] Common polygenic variations play a significant role in determining the risk for this complex trait. [17] Genome-wide association studies (GWAS) have been instrumental in identifying new genetic loci and biological pathways associated with hearing function and thresholds. [18]
Several specific genes and genetic polymorphisms have been linked to age-related hearing impairment. For instance, a single-nucleotide polymorphism (SNP) located in intron 6 of theSIK3 gene has been associated with hearing ability, suggesting its role in auditory function. [4] Variants in the GRM7gene (Glutamate Receptor Metabotropic 7) also confer susceptibility to age-related hearing impairment.[10] Additionally, the GRHL2 gene (Grainyhead Like 2) and the NAT2*6A polymorphism in the N-acetyltransferase 2 gene (NAT2) have been associated with this condition. [8] Genetic factors also contribute to an individual’s susceptibility to noise-induced hearing loss, highlighting the interplay between inherited predispositions and environmental challenges. [9]
Environmental and Systemic Influences
Section titled “Environmental and Systemic Influences”Environmental factors significantly contribute to the development and progression of age-related hearing impairment. Occupational noise exposure is recognized as a primary cause of hearing loss and represents a major occupational health concern globally.[9]Beyond noise, lifestyle factors such as smoking and a high body mass index (BMI) are identified as independent risk factors for age-related hearing impairment, while moderate alcohol consumption has been observed to have a protective effect.[2] These environmental stressors can increase physiological stress, inflammation, and oxidative stress within the body, thereby heightening an individual’s susceptibility to hearing damage. [9]
Furthermore, age-related hearing impairment is not isolated to the auditory system but can be interconnected with broader systemic health conditions. Research indicates a relationship between hearing status in the elderly and the presence of cardiovascular disease, as well as general cardiovascular risk factors.[1]Noise-induced hearing loss itself can also have wider non-auditory consequences, including cognitive impairment, sleep disturbances, and an increased risk of cardiovascular disease, underscoring the systemic impact of auditory health.[9]
Pathways and Mechanisms
Section titled “Pathways and Mechanisms”Cellular Stress Responses and Apoptosis
Section titled “Cellular Stress Responses and Apoptosis”Age-related hearing impairment involves significant cellular stress responses, with oxidative stress identified as a primary mechanism contributing to the irreversible loss of cochlear hair cells.[9] Elevated levels of reactive oxygen species (ROS) damage critical cellular components, particularly mitochondria, which subsequently activates programmed cell death pathways, known as apoptosis. [9] This process of hair cell demise is a central factor in permanent hearing loss, and studies indicate that antioxidants can reduce cellular and functional changes induced by such stress, while inhibition of apoptotic signaling pathways can prevent cochlear hair cell loss. [19]Additionally, dysregulation of extracellular potassium, potentially through compromised cell-cell junctions within the organ of Corti, can contribute to hair cell apoptosis, further illustrating the complex interplay of stress and cell fate.[9]
Ion Homeostasis and Sensory Transduction
Section titled “Ion Homeostasis and Sensory Transduction”Maintaining precise ion homeostasis, especially potassium recycling, is crucial for establishing the electrochemical gradients and mediating potassium currents that are essential for auditory function within the cochlea.[9]Genetic polymorphisms and mutations in genes encoding key potassium channels, such asKCNE1, KCNQ1, KCNQ4, KCNMA1, and KCNJ10, are known to disrupt these vital pathways, leading to hearing impairment. [9] Emerging research also implicates KCNQ3 and KCNMB2 as candidate genes, with KCNQ3 activation linked to tinnitus and its dimerization with other channels, like KCNQ4, being critical for modulating low-voltage activated potassium conductance in hair cells.[9]Beyond ion channels, variants in metabotropic glutamate receptors, includingGRM7 and GRM8, are associated with susceptibility to age-related hearing impairment, highlighting their role in the intricate synaptic transmission and neuronal signaling within the auditory system.[3]
Regulatory Signaling and Structural Integrity
Section titled “Regulatory Signaling and Structural Integrity”Cellular signaling pathways and regulatory mechanisms are fundamental for the proper development and long-term maintenance of auditory structures. The salt-inducible kinase 3 (SIK3) gene, for instance, is expressed in murine hair cells during early development and in spiral ganglion cells throughout both developmental and adult stages, underscoring its potential role in sustaining adult auditory function. [4] SIK3 is involved in the phosphorylation of the CREB-regulated transcriptional co-activator 3, thereby influencing gene regulation and potentially modulating inflammatory responses by inhibiting the formation of regulatory macrophages. [4] Furthermore, the ACAN (Aggrecan) gene, which is responsible for synthesizing extracellular matrix and collagen, is expressed in mouse auditory tissue, particularly within cochlear non-hair cells during the P7 developmental stage, indicating its importance for the structural integrity and organization of inner ear tissues. [1] While the ISG20gene is also associated with age-related hearing impairment, its specific mechanistic contributions to auditory function require further investigation.[1]
Metabolic Pathways and Cellular Detoxification
Section titled “Metabolic Pathways and Cellular Detoxification”Metabolic pathways are vital for supplying the energy and molecular components required by the highly active cells of the auditory system, and their dysregulation contributes significantly to age-related decline. The NAT2*6A polymorphism, associated with the N-acetyltransferase 2 enzyme, has been identified as a factor contributing to age-related hearing impairment, suggesting a role for metabolic detoxification processes in susceptibility.[5]Genes involved in antioxidant defense, such asCAT (catalase), HSP70 (heat shock protein 70), and SOD (superoxide dismutase), are crucial in mitigating the oxidative stress that is a primary cause of hair cell damage, thereby reflecting the importance of metabolic regulation in cellular protection. [20] The SIK3gene further exemplifies metabolic involvement, as it is known to regulate lipid storage size and plays an essential role in chondrocyte hypertrophy, functions that could indirectly influence the long-term metabolic health and structural integrity of the auditory system.[4]
Population Studies
Section titled “Population Studies”Population Prevalence and Risk Factor Associations
Section titled “Population Prevalence and Risk Factor Associations”Population studies have extensively characterized the prevalence and incidence patterns of age-related hearing impairment (ARHI), identifying key demographic and socioeconomic correlates. Research utilizing data from surveys such as the National Health and Nutrition Examination Survey (NHANES) has shed light on the overall prevalence of hearing loss among US adults and how it varies across different demographic characteristics.[21]Beyond demographic factors, epidemiological investigations have pinpointed several modifiable risk factors. For instance, a European population-based multicenter study identified occupational noise exposure, smoking, and a high body mass index as significant risk factors for ARHI, while moderate alcohol consumption was found to be protective.[2]Furthermore, studies have explored the broader health implications, establishing a relationship between hearing status in the elderly and the presence of cardiovascular disease and its associated risk factors.[1]These findings underscore the complex interplay of lifestyle, environmental, and health factors contributing to the burden of ARHI at a population level.
Large-Scale Cohort Studies and Genetic Insights
Section titled “Large-Scale Cohort Studies and Genetic Insights”Large-scale cohort studies, often leveraging extensive biobank data and electronic health records (EHRs), have been instrumental in unraveling the genetic architecture and temporal patterns of age-related hearing impairment. The Kaiser Permanente Research Program on Genes, Environment, and Health (RPGEH) and the UK Biobank have served as foundational cohorts for genome-wide association studies (GWAS) of ARHI.[1] For example, a GWAS using EHRs from the GERA cohort, comprising an average age of 62.9 years, identified cases who were more often male and older compared to controls. [1] These studies aim to discover novel genetic variants associated with ARHI, with findings suggesting a potentially similar etiology for ARHI as for other forms of hearing loss, highlighting specific genomic regions for further investigation. [1] Beyond single-cohort analyses, pleiotropic meta-analyses of longitudinal studies, such as those including non-Hispanic Caucasian subjects from the ARIC, FHS, MESA, CHS, and HRS cohorts, have provided valuable insights into the genetic underpinnings of age-related diseases, including ARHI, by analyzing longitudinal observations of various phenotypes. [22] Specific genetic variants, such as those in GRM7, have been identified as conferring susceptibility to ARHI, further demonstrating the utility of large-scale genetic epidemiology. [3]
Cross-Population Comparisons and Methodological Nuances
Section titled “Cross-Population Comparisons and Methodological Nuances”Investigations into age-related hearing impairment have also extended to diverse populations, revealing variations in prevalence and genetic associations across different ancestries and geographic regions, while simultaneously highlighting methodological considerations. Multi-ethnic cohorts, such as the GERA cohort, have enabled comparisons across non-Hispanic white, Latino, East Asian, and African American populations, though initial discovery cohorts often focus on the largest subgroups, like non-Hispanic whites.[1] Other studies have specifically recruited participants from ethnically distinct or isolated populations, such as the Saami people, to explore population-specific genetic effects. [8] Similarly, the G-EAR consortium, drawing samples from isolated villages in Italy, Croatia, and countries along the Silk Road, along with the TwinsUK cohort, has contributed to understanding hearing function across varied genetic backgrounds, identifying, for instance, the contribution of the NAT2*6A polymorphism to ARHI. [4] Methodologically, these studies employ rigorous approaches, from detailed pure-tone audiometry summarized by principal component analysis in the TwinsUK cohort, to careful exclusion criteria in EHR-based studies that remove individuals with specific ear damage or noise-induced hearing loss codes. [4] While large sample sizes and comprehensive EHRs offer broad insights, the reliance on diagnostic codes and the absence of specific hearing-related questions in general surveys can introduce limitations, necessitating the use of audiologist notes for more precise phenotyping in subsets of participants. [1]
Frequently Asked Questions About Age Related Hearing Impairment
Section titled “Frequently Asked Questions About Age Related Hearing Impairment”These questions address the most important and specific aspects of age related hearing impairment based on current genetic research.
1. My parents have hearing loss; will I definitely get it too?
Section titled “1. My parents have hearing loss; will I definitely get it too?”While your risk is higher if your parents have age-related hearing impairment, it’s not a certainty. ARHI is highly polygenic, meaning many genes contribute to your susceptibility, like variants nearISG20 or within TRIOBP. You might inherit some of these genetic predispositions, but environmental factors like noise exposure and lifestyle choices also play a significant role in its development.
2. Why do my friends hear fine but I struggle in noisy places?
Section titled “2. Why do my friends hear fine but I struggle in noisy places?”Your ability to hear clearly, especially in noisy environments, is influenced by your unique genetic makeup. Some individuals may have specific genetic variants in genes like GRM7 or GRM8 that make them more susceptible to hearing difficulties, even compared to others their age. These genetic differences can explain why ARHI progresses differently for various people.
3. Does drinking alcohol actually help my hearing as I get older?
Section titled “3. Does drinking alcohol actually help my hearing as I get older?”Interestingly, some studies have suggested that moderate alcohol consumption might offer a protective effect against age-related hearing impairment. However, this is just one potential factor among many. It doesn’t outweigh significant risk factors like genetic predispositions or exposure to loud noise, and excessive alcohol use carries its own health risks.
4. Is my old noisy job the only reason I can’t hear well now?
Section titled “4. Is my old noisy job the only reason I can’t hear well now?”While occupational noise exposure is a recognized risk factor for age-related hearing impairment, it’s rarely the sole cause. Your genetic background also plays a crucial role. For example, some people might have a genetic polymorphism likeNAT2*6A that makes them more vulnerable to developing ARHI, even with similar noise exposure compared to someone without that variant.
5. Could a DNA test tell me if I’ll get hearing loss later in life?
Section titled “5. Could a DNA test tell me if I’ll get hearing loss later in life?”While genetic research has identified many genes associated with ARHI, such as ILDR1 or EYA4, a single DNA test can’t definitively predict your future hearing loss. ARHI is very complex, involving numerous genes and environmental factors. Current tests can only indicate an increased susceptibility, not a guaranteed outcome.
6. Does my hearing just get worse as I get older, no matter what I do?
Section titled “6. Does my hearing just get worse as I get older, no matter what I do?”Age is a primary factor, but your genetic background significantly influences how and whenARHI progresses for you. While it’s a common part of aging for many, some individuals might have specific genetic variants, like those inSIK3, that make them more prone to earlier or more severe decline than others. Lifestyle choices can also impact the rate of progression.
7. Does my ethnic background affect my risk of hearing loss?
Section titled “7. Does my ethnic background affect my risk of hearing loss?”Yes, research indicates that genetic findings for age-related hearing impairment can vary across different ancestral groups. Many studies have predominantly focused on specific populations, and certain genetic risk factors might be more common or have different effects in your particular ethnic background. This can influence your overall risk and the manifestation of ARHI.
8. My sibling has much better hearing than me; why are we so different?
Section titled “8. My sibling has much better hearing than me; why are we so different?”Even within the same family, genetic differences can lead to varying susceptibilities to ARHI. You and your sibling might have inherited different combinations of the many genes involved, such as PTPRD or TRIOBP. Additionally, individual environmental exposures like specific noise levels, smoking, or even certain medications can contribute to these observed differences.
9. I’m not that old, but my hearing is already bad. Is that normal?
Section titled “9. I’m not that old, but my hearing is already bad. Is that normal?”While age-related hearing impairment typically develops later in life, some genetic factors can predispose individuals to an earlier onset or more severe form. For instance, specific variants in genes likeTRIOBP have been linked not only to ARHI but also to prelingual hearing loss, suggesting a stronger genetic component can lead to earlier problems for some.
10. Can genetics eventually help cure my hearing loss?
Section titled “10. Can genetics eventually help cure my hearing loss?”Currently, age-related hearing impairment cannot be cured, and treatments like hearing aids primarily mitigate its effects. However, the ongoing identification of genetic influences offers significant hope for future curative therapies. Understanding the specific genes involved, such asISG20 or SIK3, is crucial for developing targeted treatments that could eventually repair or prevent the underlying damage.
This FAQ was automatically generated based on current genetic research and may be updated as new information becomes available.
Disclaimer: This information is for educational purposes only and should not be used as a substitute for professional medical advice. Always consult with a healthcare provider for personalized medical guidance.
References
Section titled “References”[1] Hoffmann TJ, et al. A Large Genome-Wide Association Study of Age-Related Hearing Impairment Using Electronic Health Records. PLoS Genet. 2016;12(10):e1006419.
[2] Fransen, E., et al. “Genome-wide association analysis demonstrates the highly polygenic character of age-related hearing impairment.”Eur J Hum Genet, vol. 23, no. 6, 2015, pp. 636-641.
[3] Friedman RA, Laer LV, Huentelman MJ, Sheth SS, Eyken EV, Corneveaux JJ, Tembe WD, Halperin RF, Thorburn AQ, Thys S, et al. GRM7 variants confer susceptibility to age-related hearing impairment. Hum Mol Genet. 2009;18(4):785-96.
[4] Wolber LE, et al. Salt-inducible kinase 3, SIK3, is a new gene associated with hearing. Hum Mol Genet. 2014;23(24):6547-58.
[5] Van Eyken E, Van Camp G, Fransen E, Topsakal V, Hendrickx JJ, Demeester K, Van de Heyning P, Maki-Torkko E, Hannula S, Sorri M, et al. Contribution of the N-acetyltransferase 2 polymorphism NAT2*6A to age-related hearing impairment. J Med Genet. 2007;44(9):570-8.
[6] Manolio, T. A., et al. “Finding the missing heritability of complex diseases.” Nature, vol. 461, no. 7265, 2009, pp. 747-753.
[7] Nagtegaal, A. P., et al. “Genome-wide association meta-analysis identifies five novel loci for age-related hearing impairment.”Sci Rep, 2019, PMID: 31645637.
[8] Van Laer, L., et al. “A genome-wide association study for age-related hearing impairment in the Saami.”Eur J Hum Genet, vol. 18, no. 6, 2010, pp. 685-693.
[9] Grondin, Y., et al. “Genetic Polymorphisms Associated with Hearing Threshold Shift in Subjects during First Encounter with Occupational Impulse Noise.” PLoS One, 2015.
[10] Corneveaux, J. J., et al. “GRM7 variants confer susceptibility to age-related hearing impairment.”Hum. Mol. Genet., 18, 2009, pp. 785–796.
[11] Holliday, E. G., et al. “Insights into the genetic architecture of early stage age-related macular degeneration: a genome-wide association study meta-analysis.”PLoS One, 2013. PMID: 23326517.
[12] Hu, X., et al. “Genome-wide association study identifies multiple novel loci associated with disease progression in subjects with mild cognitive impairment.”Transl Psychiatry, 2012. PMID: 22833209.
[13] Croxson, S. C., and C. Jagger. “Diabetes and cognitive impairment: a community-based study of elderly subjects.”Age Ageing, 1995.
[14] Lucin, K. M., and T. Wyss-Coray. “Immune activation in brain aging and neurodegeneration: too much or too little?”Neuron, 2009.
[15] Böttger, E. C., and J. Schacht. “The mitochondrion: a perpetrator of acquired hearing loss.” Hear Res., 245, 2013, pp. 1–7.
[16] Zheng, G., and B. H. Hu. “Cell-cell junctions: a target of acoustic overstimulation in the sensory epithe.” Hear Res, 290, 2012, pp. 1–9.
[17] Purcell, S. M., et al. “Common polygenic variation contributes to risk of schizophrenia and bipolar disorder.”Nature, 460, 2009, pp. 748–752.
[18] Girotto, G., et al. “Hearing function and thresholds: a genome-wide association study in European isolated populations identifies new loci and pathways.” J. Med. Genet., 48, 2011, pp. 369–374.
[19] Lu, J., et al. “Antioxidants Reduce Cellular and Functional Changes Induced by Intense Noise in the Inner Ear and Cochlear Nucleus.” J Assoc Res Otolar, 2014.
[20] Konings, A., et al. “Association Between Variations in CAT and Noise-Induced Hearing Loss in Two Independent Noise-Exposed Populations.” Hear Res, 2007.
[21] Agrawal, Y., Platz, E. A., & Niparko, J. K. “Prevalence of hearing loss and differences by demographic characteristics among us adults: Data from the national health and nutrition examination survey, 1999–2004.” Archives of Internal Medicine, 2008.
[22] He, L., Liu, Y., Zhang, Y., et al. “Pleiotropic Meta-Analyses of Longitudinal Studies Discover Novel Genetic Variants Associated with Age-Related Diseases.” Frontiers in Genetics, vol. 7, 2016, p. 195.